Trials / Completed
CompletedNCT01095211
B-vitamins Treatment for Improvement of Cognitive Function
Effect of B-Vitamins on Cognitive Function in Elderly People
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 79 (actual)
- Sponsor
- Universität des Saarlandes · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
Observation studies documented a correlation between plasma concentrations of homocysteine and cognitive decline with age. The study hypothesis was that high doses of B-vitamins (as effective homocysteine lowering treatment) can improve cognitive function in elderly people.
Detailed description
We performed a treatment with therapeutic doses of B-vitamins (folic acid, cobalamin, vitamin B6) for 45 days. We collected blood and tested the concentrations of the metabolic markers in blood at start, 3 weeks later and at the end. Cognitive function was tested at start and at the end.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | B-vitamin complex | 5 mg Folic acid, plus 1 mg cyanocobalamin and 40 mg vitamin B6) oral/ day. The placebo capsule contained 400 mg of mannitol: aerosil (99.5: 0.5). In addition, 1 mg/s.c cyanocobalamin daily |
Timeline
- Start date
- 2003-01-01
- Primary completion
- 2005-09-01
- Completion
- 2009-12-01
- First posted
- 2010-03-30
- Last updated
- 2018-05-11
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01095211. Inclusion in this directory is not an endorsement.